Integrating Imaging-Based Biomarkers to Advance Precision in IBD Clinical Trials

• Maximizing the value of endoscopy by driving consistency in centralized reads
• Opportunities and challenges with deploying MRI based biomarkers in global clinical trials
• Emerging opportunities for AI tools to automate and accelerate central reviews

Speakers:

Sarah Sherlock

Clinical Imaging, Early Clinical Development, R Head I

AstraZeneca